Cargando…

Comparative analysis of ascorbic acid in human milk and infant formula using varied milk delivery systems

BACKGROUND: The expression of human milk for later use is on the rise. Bottle systems are used to deliver the expressed milk. Research has shown that storage of both human milk and artificial baby milk, or infant formula, leads to a loss of ascorbic acid (commonly called Vitamin C). As milk is remov...

Descripción completa

Detalles Bibliográficos
Autores principales: Francis, Jimi, Rogers, Kristy, Brewer, Paul, Dickton, Darby, Pardini, Ron
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526073/
https://www.ncbi.nlm.nih.gov/pubmed/18694505
http://dx.doi.org/10.1186/1746-4358-3-19
_version_ 1782158717313089536
author Francis, Jimi
Rogers, Kristy
Brewer, Paul
Dickton, Darby
Pardini, Ron
author_facet Francis, Jimi
Rogers, Kristy
Brewer, Paul
Dickton, Darby
Pardini, Ron
author_sort Francis, Jimi
collection PubMed
description BACKGROUND: The expression of human milk for later use is on the rise. Bottle systems are used to deliver the expressed milk. Research has shown that storage of both human milk and artificial baby milk, or infant formula, leads to a loss of ascorbic acid (commonly called Vitamin C). As milk is removed from the bottle during feeding and replaced by ambient air, it is unknown if loss of ascorbic acid occurs during the course of a feeding. The purpose of this study is to investigate the effect of the milk delivery system on levels of ascorbic acid in human milk and infant formula. The objectives are to 1) determine changes in ascorbic acid concentration during a 20 minute "feed," 2) determine if there is a difference in ascorbic acid concentration between delivery systems, and 3) evaluate if any differences are of clinical importance. METHODS: Commonly available bottles were used for comparison of bottle delivery systems. Mature human milk was standardized to 42 mg/L of ascorbic acid. Infant formula with iron and infant formula with docosahexanoic acid were used for the formula samples. Each sample was analyzed for ascorbic acid concentration at baseline (0), 5, 10, 15, and 20 minutes. Each collection of samples was completed in triplicate. Samples were analyzed for ascorbic acid using normal-phase high performance liquid chromatography. RESULTS: Ascorbic acid concentration declined in all bottle systems during testing, Differences between the bottle systems were noted. Ascorbic acid concentrations declined to less than 40% of recommended daily intake for infants in 4 of the bottles systems at the 20 minute sampling. CONCLUSION: The bottle systems used in this study had measurable decreases in the mean concentration of ascorbic acid. More research is needed to determine if the observed decreases are related to lower plasma ascorbic acid concentration in infants exclusively bottle fed. The decrease of ascorbic acid concentration observed in both human milk and infant formula using varied milk delivery systems may be of clinical importance. For infants who rely solely on bottle feeds there may be increased risk of deficiency. Bottle shape, size, and venting should be considered.
format Text
id pubmed-2526073
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25260732008-08-28 Comparative analysis of ascorbic acid in human milk and infant formula using varied milk delivery systems Francis, Jimi Rogers, Kristy Brewer, Paul Dickton, Darby Pardini, Ron Int Breastfeed J Research BACKGROUND: The expression of human milk for later use is on the rise. Bottle systems are used to deliver the expressed milk. Research has shown that storage of both human milk and artificial baby milk, or infant formula, leads to a loss of ascorbic acid (commonly called Vitamin C). As milk is removed from the bottle during feeding and replaced by ambient air, it is unknown if loss of ascorbic acid occurs during the course of a feeding. The purpose of this study is to investigate the effect of the milk delivery system on levels of ascorbic acid in human milk and infant formula. The objectives are to 1) determine changes in ascorbic acid concentration during a 20 minute "feed," 2) determine if there is a difference in ascorbic acid concentration between delivery systems, and 3) evaluate if any differences are of clinical importance. METHODS: Commonly available bottles were used for comparison of bottle delivery systems. Mature human milk was standardized to 42 mg/L of ascorbic acid. Infant formula with iron and infant formula with docosahexanoic acid were used for the formula samples. Each sample was analyzed for ascorbic acid concentration at baseline (0), 5, 10, 15, and 20 minutes. Each collection of samples was completed in triplicate. Samples were analyzed for ascorbic acid using normal-phase high performance liquid chromatography. RESULTS: Ascorbic acid concentration declined in all bottle systems during testing, Differences between the bottle systems were noted. Ascorbic acid concentrations declined to less than 40% of recommended daily intake for infants in 4 of the bottles systems at the 20 minute sampling. CONCLUSION: The bottle systems used in this study had measurable decreases in the mean concentration of ascorbic acid. More research is needed to determine if the observed decreases are related to lower plasma ascorbic acid concentration in infants exclusively bottle fed. The decrease of ascorbic acid concentration observed in both human milk and infant formula using varied milk delivery systems may be of clinical importance. For infants who rely solely on bottle feeds there may be increased risk of deficiency. Bottle shape, size, and venting should be considered. BioMed Central 2008-08-11 /pmc/articles/PMC2526073/ /pubmed/18694505 http://dx.doi.org/10.1186/1746-4358-3-19 Text en Copyright © 2008 Francis et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Francis, Jimi
Rogers, Kristy
Brewer, Paul
Dickton, Darby
Pardini, Ron
Comparative analysis of ascorbic acid in human milk and infant formula using varied milk delivery systems
title Comparative analysis of ascorbic acid in human milk and infant formula using varied milk delivery systems
title_full Comparative analysis of ascorbic acid in human milk and infant formula using varied milk delivery systems
title_fullStr Comparative analysis of ascorbic acid in human milk and infant formula using varied milk delivery systems
title_full_unstemmed Comparative analysis of ascorbic acid in human milk and infant formula using varied milk delivery systems
title_short Comparative analysis of ascorbic acid in human milk and infant formula using varied milk delivery systems
title_sort comparative analysis of ascorbic acid in human milk and infant formula using varied milk delivery systems
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526073/
https://www.ncbi.nlm.nih.gov/pubmed/18694505
http://dx.doi.org/10.1186/1746-4358-3-19
work_keys_str_mv AT francisjimi comparativeanalysisofascorbicacidinhumanmilkandinfantformulausingvariedmilkdeliverysystems
AT rogerskristy comparativeanalysisofascorbicacidinhumanmilkandinfantformulausingvariedmilkdeliverysystems
AT brewerpaul comparativeanalysisofascorbicacidinhumanmilkandinfantformulausingvariedmilkdeliverysystems
AT dicktondarby comparativeanalysisofascorbicacidinhumanmilkandinfantformulausingvariedmilkdeliverysystems
AT pardiniron comparativeanalysisofascorbicacidinhumanmilkandinfantformulausingvariedmilkdeliverysystems